A phase 3, double-blind, randomized, placebo-controlled study of the safety and efficacy of adefovir dipivoxil in children and adolescents (age 2 to less than 18) with chronic hepatitis B.
Phase of Trial: Phase III
Latest Information Update: 22 May 2012
At a glance
- Drugs Adefovir dipivoxil (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 02 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Jun 2011 Additional lead investigator (John Flaherty) added as reported by ClinicalTrials.gov.
- 01 Jun 2008 Results have been published in Hepatology.